Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 52.78B | 53.61B | 50.60B | 55.36B | 49.89B | 40.65B |
Gross Profit | 7.98B | 8.18B | 6.84B | 7.29B | 7.23B | 6.65B |
EBITDA | 4.02B | 5.20B | 4.00B | 4.39B | 3.87B | 3.53B |
Net Income | 1.52B | 1.54B | 546.00M | 977.00M | 1.40B | 1.00B |
Balance Sheet | ||||||
Total Assets | 70.96B | 67.86B | 69.94B | 67.95B | 66.49B | 58.42B |
Cash, Cash Equivalents and Short-Term Investments | 7.55B | 5.90B | 6.75B | 6.08B | 7.50B | 9.29B |
Total Debt | 28.45B | 28.58B | 30.26B | 29.94B | 28.18B | 24.59B |
Total Liabilities | 51.01B | 46.78B | 50.78B | 50.19B | 49.58B | 43.30B |
Stockholders Equity | 19.87B | 20.99B | 19.08B | 17.69B | 16.81B | 15.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 450.00M | 1.40B | -3.15B | -5.03B | -839.00M |
Operating Cash Flow | 0.00 | 3.30B | 3.40B | 1.70B | -572.00M | 2.46B |
Investing Cash Flow | 0.00 | -2.55B | -1.93B | -4.59B | -4.50B | -3.31B |
Financing Cash Flow | 0.00 | -1.86B | -900.00M | 1.42B | 3.11B | 1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥17.54B | 11.87 | 3.59% | 4.85% | 80.14% | ||
79 Outperform | ¥18.87B | 9.83 | 3.51% | 0.78% | -5.93% | ||
76 Outperform | ¥17.65B | 7.90 | 4.27% | 12.71% | 123.52% | ||
76 Outperform | ¥16.08B | 4.71 | 8.96% | 3.08% | 12.74% | ||
74 Outperform | ¥17.32B | 11.07 | 2.46% | 5.96% | 182.60% | ||
73 Outperform | ¥17.89B | 6.99 | 4.53% | 0.79% | 60.97% | ||
44 Neutral | C$979.74M | -6.70 | -13.35% | 2.68% | 17.20% | -32.62% |